Grin (also Grinsphon), Eugene of Laurus Capital Management, LLC
Eugene Grin (also Grinsphon) of Laurus Capital Management, LLC
Eugene Grin was originally from Ukraine. He came to the US in 1979 and became a vacuum cleaner salesman. After that he worked as a broker of penny stocks at F.N. Wolf & Company. While employed at Wolf, Grin managed a client named Gilbert Bornstein, a 54-year old unemployed man who invested $32,000 with Grin after being convinced he could safely double his money through penny stocks. Bornstein was soon stuck with $27,000 in losses. Nine years afterwards, a New York state judge determined that Grin owned Bornstein $40,000. Grin has yet to pay that bill, and the judgment remains outstanding. Grin was quoted as saying “He was super wealthy, there was money in the family.”
Eugene Grin is quoted in Feb. 2004 regarding a Laurus investment in Inyx, Inc., a drug delivery company. Earlier they made an investment in Equifin.
“Ongoing investigations by IBARC in New York, Liechtenstein, the British Virgin Islands, Grand Cayman Islands, Isle of Man, United Kingdom, Italy, Panama, and Switzerland into such funds as Laurus Master Fund Ltd., The Keshet Fund L.P., Keshet L.P., Nesher Ltd., Talbiya B. Investments Ltd., Esquire Trade & Finance Inc., Amro International and dozens of others are turning up initial evidence related to about two hundred companies in the United States whose stockholders have lost over $100 billion in value over the past decade through toxic financing schemes arranged by various organized crime syndicates managed out of New York City.”
In September of 2004, Laurus Capital management LLC notified Global Digital that they were in default for non-payment of interest due under its borrowing agreement.
The Grins have built up their Laurus Family of Funds to one of the nation’s largest investors in penny stocks in 2006.
Eugene Grin is quoted in Feb. 2004 regarding a Laurus investment in Inyx, Inc., a drug delivery company. Earlier they made an investment in Equifin.
Many of the lawsuits and negative media articles refer to a financing technique called “death spiral” financing.
Laurus is a financial institution that makes direct, secured investments to small and micro-cap public companies.
The attorneys in the Endovasc case comment on their suit filed against Laurus Funds.
Endovasc Provides Status Report on Its $200 Million Case against Alleged Stock Manipulators
MONTGOMERY, Texas Endovasc Inc. (OTCBB: EVSC), a drug development company that pioneers new cardiovascular and metabolic drug therapies, announced today an update on the Company’s civil lawsuit against J.P. Turner & Co. LLC et al Inc., Number 02-CV-7313, in the United States District Court, Southern District of New York. The complaint is for damages as a result of an alleged fraud and stock manipulation. The Company is seeking monetary damages in excess of $200,000,000.
250 articles were found that mention “Laurus Funds”. Many appear to announce investments and loans made to small cap companies.
In 2003, the Wall Street Journal quotes Laurus as “The $500 million Laurus Funds hedge fund says it has pioneered a new financing model for micro caps where Laurus provides debt to small publicly traded companies that is convertible into equity. “
UTEK corp. agrees to sell 350,000 shares of its common stock to Laurus Capital Management .The net proceedings are approximately $ 3,700,000.
In September of 2004, Laurus Capital management LLC notified Global Digital that they were in default for non-payment of interest due under its borrowing agreement.


